MARKET

ANIK

ANIK

Anika
NASDAQ

Real-time Quotes | Nasdaq Last Sale

28.47
-0.44
-1.52%
Closed 16:59 04/01 EDT
OPEN
28.56
PREV CLOSE
28.91
HIGH
30.04
LOW
27.38
VOLUME
168.32K
TURNOVER
--
52 WEEK HIGH
75.72
52 WEEK LOW
22.01
MARKET CAP
403.37M
P/E (TTM)
14.99
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ANIK stock price target is 62.00 with a high estimate of 65.00 and a low estimate of 60.00.

EPS

ANIK News

More
  • How Does Anika Therapeutics's (NASDAQ:ANIK) P/E Compare To Its Industry, After The Share Price Drop?
  • Simply Wall St. · 6d ago
  • The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
  • Benzinga · 03/18 11:36
  • Can You Imagine How Anika Therapeutics's (NASDAQ:ANIK) Shareholders Feel About The 29% Share Price Increase?
  • Simply Wall St. · 03/11 12:51
  • Anika Appoints David Colleran as General Counsel
  • Business Wire · 03/04 13:30

Industry

Pharmaceuticals
-2.46%
Pharmaceuticals & Medical Research
-2.91%

Hot Stocks

Symbol
Price
%Change

About ANIK

Anika Therapeutics, Inc. is an orthopedic medicines company. The Company is engaged in developing, manufacturing and commercializing products based on its hyaluronic acid (HA) technology. The Company's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration. The Company's therapeutic offerings consist of products in the areas, including Orthobiologics, which includes viscosupplementation and regenerative orthopedic products; Dermal, which includes wound care products; Surgical, which includes products used to prevent post-surgical adhesions, and Other, which includes the Company's ophthalmic and veterinary products. The Company also offers products made from HA based on two other technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA.
More

Webull offers kinds of Anika Therapeutics Inc stock information, including NASDAQ:ANIK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIK stock news, and many more online research tools to help you make informed decisions.